NINGBO INNO PHARMCHEM CO.,LTD. is pleased to highlight the growing importance of Phenylacetylglutamine (CAS 28047-15-6) in the field of health and metabolic monitoring. As a key human metabolite, Phenylacetylglutamine has garnered significant attention for its potential as a reliable indicator of metabolic age. Its presence and concentration in urine can provide valuable insights into the physiological aging process and its associated health markers.

The utility of Phenylacetylglutamine extends beyond age-related studies. It is intricately linked to the urea cycle, playing a crucial role in the efficient removal of nitrogenous waste products from the body. This function makes it particularly relevant for individuals with urea cycle disorders, where alternative pathways for nitrogen excretion are critical. Understanding the phenylacetylglutamine urea cycle support mechanisms can pave the way for improved therapeutic strategies.

Furthermore, emerging research points to Phenylacetylglutamine as a significant phenylacetylglutamine kidney disease indicator. Elevated levels of this metabolite in urine have been observed in individuals with chronic kidney disease, suggesting its potential as a non-invasive biomarker for assessing renal function decline. By monitoring phenylacetylglutamine in human urine, healthcare professionals may gain a better understanding of kidney health.

The compound's connection to cardiovascular health is also a growing area of interest. Studies are investigating Phenylacetylglutamine as a cardiovascular health metabolite, exploring its association with conditions such as heart failure and coronary in-stent restenosis. The potential for Phenylacetylglutamine to serve as an early warning sign for cardiovascular issues underscores its multifaceted health significance.

For researchers and pharmaceutical developers, Phenylacetylglutamine represents a valuable phenylacetylglutamine pharmaceutical intermediate. Its unique chemical structure and biological roles make it a compound of interest for drug development and further scientific investigation. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality Phenylacetylglutamine to support these vital research efforts, enabling advancements in understanding and managing metabolic and age-related health conditions.